Nath Bio-Genes Ltd (NATHBIOGEN)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 169.79
% Change: -1.28% (Prev Close: 171.99)

Volume: 17,607
% Change: 10.17% (Prev Volume: 15,982)

Delivery: 0
Delivery % : 0.00
% Change: 0.00% (Prev Delivery: 0)

Turnover: 30 Lacs
% Change: 9.47% (Prev Turnover: 27)

πŸ’Ή EOD Valuation

P/E Ratio: 6.66
P/B Ratio: 0.50
Market Cap: 323 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: NATHBIOGEN
Market Cap: 325 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 238.69
52 Week Low: 137.55

All-Time High: 585.00 Rs.
All-Time Low: 38.90 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.46% | -11.82% | 6.52% | -22.89% | -1.51%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 45.59%

Change (3Y | 1Y): 4.52% | -0.01%

Pledged %: 13.78%

FII Holding

FII Holding: 0.41%

Change (3Y | 1Y): 0.30% | 0.20%

DII Holding

DII Holding: 2.25%

Change (3Y | 1Y): -2.37% | -1.69%

Public Holding: 51.73%

🏦 Financial Strength

Debt to Equity: 0.17
Debt: 111.14 Rs. Cr.

Book Value: 341.33 Rs.
Current Ratio: 1.87
Interest Coverage: 5.68
Free Cash Flow: 19.16 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 16.81%

Sales Growth Qtr (YOY | QoQ):
14.88% | 467.49%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
1.50% | 4.83% | 16.81%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 16.96%

Profit Growth Qtr (YOY | QoQ):
6.67% | 711.25%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-3.32% | 21.46% | 16.96%

EPS Rs.

EPS (TTM): 25.51 Rs.

EPS Qtr (Last Year | Latest):
17.83 Rs. | 20.11 Rs.

EPS Annual (Last Annual | Annual March):
21.14 Rs. | 22.17 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-3.32% | 21.46%

Net Profit Rs. Cr.

Net Profit (TTM): 48.47 Rs. Cr.

Net Profit (Annual - March): 42.14 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
33.89| 4.71 | 38.21

EBITDA Rs. Cr.

EBITDA (Quarter): 40.67 Rs. Cr.
EBITDA (Previous Yr Ql): 37.20 Rs. Cr.

EBITDA (Annual - March): 58.17 Rs. Cr.
EBITDA (Previous Annual): 51.12 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.56% | 14.14%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 14.08%

OPM Qtr (Previous | Current):
6.42% | 13.88%

OPM Annual (5 Yrs | Last Yr | March):
20.59% | 20.39% | 20.14%

Return on Equity %

ROE: 6.77%

ROE (5 Yrs | 3 Yrs | Last Yr):
6.60% | 6.44% | 6.23%

Return on Capital Employed %

ROCE: 7.35%

ROCE (5 Yrs | 3 Yrs | Last Yr):
7.28% | 7.10% | 6.85%

Return on Assets %

ROA (TTM): 4.50%

ROA (5 Yrs | 3 Yrs | Last Yr):
4.79% | 4.50% | 4.42%

PEG Ratio: 0.33
Dividend Yield: 1.17%

PE 3 Yrs: 10.20
PE 5 Yrs: 10.13

Dividend Yield: 1.17%

πŸ‘₯ Company

Nath Bio-Genes Ltd

NATHBIOGEN

Promoter Holding: %